Recruiting studies: Low Dose Radiotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07448142 A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT06052683 De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
NA · 1 location(s) · Georgetown University · NCT06554158 The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy
Phase 2 · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT06503276 Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT07201337 LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Phase 2 · 2 location(s) · Sun Yat-sen University · NCT07325539 A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Phase 1 · 3 location(s) · Memorial Sloan Kettering Cancer Center · NCT05296304 Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer
NA · 1 location(s) · Denise Fabian · NCT07631572 LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 · 2 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06848465 Telecommunication Technology-based Online Survey
Phase N/A · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT06159699 Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced
Phase 2 · 6 location(s) · Sichuan University · NCT06121505 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT04427566 Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Phase 1/Phase 2 · 1 location(s) · Sichuan University · NCT06217757 Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
Phase 2/Phase 3 · 4 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT03051464 Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06525428 Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT05887284 Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma
Phase 2 · 2 location(s) · Zhejiang Cancer Hospital · NCT07554898 Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carc
Phase 2 · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT07277764 Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.
Phase 4 · 1 location(s) · Hospital JP Garrahan · NCT03500133 Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT02653079 LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
Phase 2 · 8 location(s) · Hunan Cancer Hospital · NCT06788002 Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal
Phase 2 · 1 location(s) · Chuangzhen Chen · NCT07339488 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Phase 3 · 15 location(s) · Ming-Yuan Chen · NCT07328854 TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06125483 Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negati
Phase 2 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07276880 Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
Phase 3 · 5 location(s) · Vejle Hospital · NCT04095299 Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer
NA · 1 location(s) · Branch Office of "Hadassah Medical Ltd" · NCT07112781 Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
NA · 1 location(s) · University of Zurich · NCT06360627 Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Phase 2 · 1 location(s) · Chuangzhen Chen · NCT07071103 Low-Dose Radiotherapy for Alzheimer's Disease
Phase 1/Phase 2 · 1 location(s) · Evan Thomas · NCT07693140

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.